Clinical trials recruiting in Kempten (Allgäu), Germany
6
Recruiting trials
11
Conditions
Phase breakdown
Phase 3 3Not applicable 3
Conditions recruiting in Kempten (Allgäu), Germany
Recruiting trials in Kempten (Allgäu), Germany
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany
- PROCARE - PROstate Cancer Real World Evidence Registry
Common questions
How many clinical trials are recruiting in Kempten (Allgäu), Germany?
6 recruiting trials have at least one study site in Kempten (Allgäu), Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.